Srs Capital Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 84 shares of HRMY stock, worth $2,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84
Previous 112
25.0%
Holding current value
$2,390
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
263Shares Held
47MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$188 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$166 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$135 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$64.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$45 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.68B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...